Clinical trends for 2023
After the tragedies of the COVID-19 pandemic and the Ukraine war, there’s hope that 2023 will see a new wave of clinical research.
Source: labiotech.eu
Page 30 - Sofinnova Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sofinnova Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sofinnova Partners Today - Breaking & Trending Today
PeptiDream : Amolyt Pharma Announces Series C Financing
Lyon, France, and Cambridge, MA, January 6, 2023 - Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today... | January 10, 2023
Source: marketscreener.com
Private Equity Acquires A Taste For Drug Development
Private equity firms that deemed drug development too risky for their liking in the past are increasingly investing in the sector, raising dedicated funds and coming up with deals that compensate
Source: ibtimes.com
Amolyt Pharma Raises $138M in Series C Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
EQS-News: Andera Partners participates in the $138 Million Series C Financing of Amolyt Pharma led by Sofinnova Partners and co-led by Intermediate Capital Group
EQS-News: Andera Partners / Key word(s): Financing Andera Partners participates in the $138 Million Series C Financing of Amolyt Pharma led by Sofinnova Partners and co-led by Intermediate
Source: finanznachrichten.de